DermTech, Inc.

Constellation Alpha Capital Corp, trading under the ticker CNAC, was a healthcare-focused special purpose acquisition company sponsored by Constellation Alpha Capital LLC that completed its initial public offering in 2017. The company filed a 10-K with the SEC on June 14, 2019, reflecting its operational status as it advanced toward a business combination with DermTech, Inc., a precision dermatology diagnostics firm focused on non-invasive genomic testing for skin cancer detection. The transaction marked CNAC's conversion from a blank-check vehicle into an operating company within the dermatology and molecular diagnostics sector. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on CNAC and hundreds of other SPACs.